ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Motivational Interviewing for Long-term Sick Absence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03212118
Recruitment Status : Recruiting
First Posted : July 11, 2017
Last Update Posted : November 13, 2017
Sponsor:
Collaborators:
University of Bergen
University of Oslo
National Center for Occupational Rehabilitation, Rauland
Deakin University
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:

Long-term sickness absence has considerable impact on social functioning, families involved, the employer, and society as a whole. Preventing long-term sickness absence and increase the likelihood of return to work (RTW) are critical concerns for industrialized countries across the world. Motivational factors contributing to RTW and maintenance of work participation are therefore of importance to explore in order to get the person back to work after long-term sick leave. Motivational interviewing (MI) is an empirically validated psychological approach that may be particularly useful in a RTW context. Even though MI has been widely studied and is considered a flexible intervention strategy in different domains, its effectiveness in improving RTW has not yet been studied.

The aim of this study is to evaluate whether MI provided by trained caseworkers at The Norwegian Labour and Welfare Administration (NAV) to sick-listed users with unselected diagnoses facilitates RTW compared with follow-up as usual.


Condition or disease Intervention/treatment Phase
Sick Leave Behavioral: Treatment as usual (TAU-0) Behavioral: Structured talks (TAU-2) Behavioral: motivational interviewing (MI) Not Applicable

Detailed Description:

The main study will be preceded by a pilot study (anticipated start medio august 2017). The aim of the pilot is to test the practical aspects of the study. If no changes are made to the study protocol, the intervention or one of the other arms, participants from the pilot will be included in the main study, In case of modifications to the study protocol after the pilot, participants from the pilot study will not be included in the main study. Data for primary and secondary outcomes will not be assessed before the end of the main study.

In addition to the intention to treat and per protocol analyses, subgroup analyses will be performed if sufficient power for age, gender, diagnoses for sick leave, occupational category and length of previous sick leave.

In addition to the effect evaluation, qualitative studies, a feasibility/process evaluation study and a health economic evaluation (cost-effectiveness, cost-utility and cost-benefit) will be performed. The qualitative studies will be based on data from focus group discussions. The main areas for investigation will be:

  • The participants' expectations to return to work before and after motivational interviewing.
  • Perceived facilitators and obstacles for return to work among participants
  • The perceived benefits and challenges in using motivational interview to facilitate a return to work process

Changes made Sept.29 2017: Due to slow recruitment, it was decided to leave out one of the arms from the study (TAU-1: extra phone call to employer). The extra phone call element was also taken out from the other arms where it was included. Another reason for this change was that the TAU-1 intervention arm was not ideally designed to evaluate the extra phone call. It was decided this intervention arm is better evaluated in a separate trial. Currently 12 persons are included and randomized in the trial. Those who are randomized to TAU-1 and have not received an intervention, will be randomized again. The ones randomized to TAU-1 who already have got an intervention will stop participating in the study.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 750 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Effects of Motivational Interviewing for Long-term Sick Absence: A Randomized Controlled Trial With Mixed Methods
Actual Study Start Date : August 14, 2017
Estimated Primary Completion Date : February 2020
Estimated Study Completion Date : March 2020

Arm Intervention/treatment
Treatment as usual
Treatment as usual "untouched". This is the standard The Norwegian Labour and Welfare Administration (NAV) procedure.
Behavioral: Treatment as usual (TAU-0)
The standard NAV procedure, which consists of a telephone call within 8 weeks to an employer who have employees on 100% sick leave, in addition to regular NAV conversations "on-demand" (not "fixed intervals") between the NAV caseworkers and the employees.
Other Name: 'untouched'

Active Comparator: Two talks
Two standard talks (not including elements from motivational interviewing)
Behavioral: Structured talks (TAU-2)
Two structured talks (not including elements from motivational interviewing)
Other Name: non-MI

Experimental: Motivational interviewing
Two standard talks with a motivational interviewing content.
Behavioral: motivational interviewing (MI)
Two structured talks (must have a valid motivational interviewing content).
Other Name: MI




Primary Outcome Measures :
  1. Total number of sickness absence days during the year after enrollment in the study (i.e. after randomization) [ Time Frame: 12 months ]
    Register data from the national health and welfare services


Secondary Outcome Measures :
  1. The time until full sustainable return to work (RTW), i.e. for at least 4 weeks without relapse [ Time Frame: 12 months ]
    Register data from the national health and welfare services

  2. Probability of working (i.e. not receiving medical benefits) each month during follow-up, measured as repeated events [ Time Frame: 12 months ]
    Register data from the national health and welfare services

  3. Return to Work Self-Efficacy [ Time Frame: 12 months ]
    Return to Work Self-Efficacy Scale (Lagerveld et al, 2010)

  4. Resilience [ Time Frame: 12 months ]
    Resilience Scale for Adults (Friborg et al, 2003)

  5. Return to work expectations [ Time Frame: 12 months ]
    Expectations about length of sick leave and return to work (3 items)

  6. Workability [ Time Frame: 12 months ]
    Single question. How will you rate your work ability (scale from 0 (no ability) to 10 (my best ability)) (1 item)

  7. Health-related quality of life [ Time Frame: 12 months ]
    EQ- 5D- 5L Questionnaire, Herdman et al, 2011


Other Outcome Measures:
  1. Pain [ Time Frame: 12 months ]
    Brief Pain Inventory (BPI), 1 item

  2. Fatigue [ Time Frame: 12 months ]
    Fatigue Severity Scale (FFS), 1 item

  3. Sleep problems [ Time Frame: 12 months ]
    Insomnia Severity Index, 5 items

  4. Anxiety symptoms [ Time Frame: 12 months ]
    Generalized Anxiety Disorder 7-item (GAD-7)

  5. Depression symptoms [ Time Frame: 12 months ]
    Patient Health Questionnaire (PHQ-9)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Living in the county Sør-Trøndelag
  • On sick leave for 8 weeks
  • Current sick leave status of 50-100%

Exclusion Criteria:

  • no employment
  • pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03212118


Contacts
Contact: Egil Andreas Fors, phd 0047 41236597 egil.a.fors@ntnu.no
Contact: Lene Aasdahl, phd 0047 93224342 lene.aasdahl@ntnu.no

Locations
Norway
Dept Recruiting
Trondheim, Norway
Contact: Lene Aasdahl, phd       lene.aasdahl@ntnu.no   
Sponsors and Collaborators
Norwegian University of Science and Technology
University of Bergen
University of Oslo
National Center for Occupational Rehabilitation, Rauland
Deakin University
Investigators
Principal Investigator: Egil Andreas Fors, phd prof Norwegian University of Science and Technology

Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT03212118     History of Changes
Other Study ID Numbers: 2016/2300-C
First Posted: July 11, 2017    Key Record Dates
Last Update Posted: November 13, 2017
Last Verified: November 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Norwegian University of Science and Technology:
Sick Leave
Return to work
Motivational interviewing
Absenteeism
Occupational Health